Restaging the Biochemical Recurrence of Prostate Cancer with [68Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease Management.

Aloÿse FourquetLucien LahmiTimofei RusuYazid BelkacemiGilles CréhangeAlexandre de la TailleGeorges FournierOlivier CussenotMathieu Gauthé

Published in: Cancers (2021)

[68Ga]Ga-PSMA-11 PET/CT demonstrated high performance in locating PCa recurrence sites and impacted therapeutic management in nearly two out of three patients.

Keyphrases

pet ct
prostate cancer
end stage renal disease
positron emission tomography
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
free survival